Slide 1: IT Conference
IT Conference 24 FEBRUARY 2021
Slide 2: Disclaimer
Disclaimer This document has been prepared by Datalogic S.p.A. (the "Company") for use during meetings with investors and financial analysts and is solely for information purposes. The information set out herein has not been verified by an independent audit company. Neither the Company nor any of it
Slide 3: Corporate Overview
Corporate Overview 3
Slide 4: Datalogic at a glance
Datalogic at a glance Global technology leader in the automatic data capture and process automation markets, in the Retail, Manufacturing, Transportation & Logistics, and Healthcare industries Founded in 1972, listed on the Italian Stock Exchange since 2001 1,200+ patents filed and more than 350 in
Slide 5: Over 45 years of Technological Innovation
Over 45 years of Technological Innovation EXPANSION ▪ Minec AB ▪ Laservall SpA ▪ Informatics Inc. NEW STRATEGY ▪ PSC Inc ▪ Set up new One EXPANSION ▪ Datasensor SpA 2012 Datalogic 1972 ▪ Escort Memory 2001 ▪ Evolution Robotic ▪ New organization by 2020 Systems Inc. Retail Inc. 2015 verticals ▪ IDWar
Slide 6: Solid long-term growth
Solid long-term growth Sales CAGR 2001-2019 +10% € mln 1000 16% 17% 16% 15% 14% 16% 17% 17% 16% 14% 14% 14% 14% 13% 12% 13% 13% 15% 900 10% 10% 800 6% 10% 10% ▪ A history of growth in 8% 8% 8% 8% 5% profitability 700 5% 6% 6% 6% 7% 4% 4% 5% 5% 606 631 612 0% ▪ Strong improvements across 600 1% 1% 2%
Slide 7: A Wide Geographical Footprint
A Wide Geographical Footprint 10 Manufacturing & Repair sites 11 R&D Centers, 3 DL Labs Direct presence in 28 countries Percent on 9M 2020 Revenues EMEAI 51.7% Americas 32.4% APAC 15.9% Data refer to YE 2020 except for revenue breakdown by Geographic area at 9M 2020 7
Slide 8: Stock and Governance
Stock and Governance Market Segment: STAR MTA Ticker: DAL Reuters Code: DAL.MI Price (February 19, 2021): 16.12 Euro Bloomberg Code: DAL IM Market Cap (February 19, 2021): 942 mln Euro Outstanding Shares: 58,446,491 Auditing Company: Deloitte Share Par-Value: 0.52 Euro each DATALOGIC SHARE PERFORMAN
Slide 9: Strategy
Strategy 9
Slide 10: Total Addressable Market
Total Addressable Market TAM: DATALOGIC MKT SHARE ~ 12.4 bln USD • Fixed retail scanners Healthcare #1 WW: > 35% market share Healthcare 4% T&L 12% • Stationary industrial scanners T&L #1 WW: = 20% market share Retail • Handheld Scanners #3 WW: ≈ 20% market share Manufacturing Retail Manufacturing 2
Slide 11: A wide range of products that is able to fulfill our customers' needs
A wide range of products that is able to fulfill our customers’ needs for both data collection and process automation Most complete offer of barcode readers: from retail to Complementary/Open doors products in industrial scanners, from hand held to mobile the MFG Industry Undisputed leadership on ba
Slide 12: Our products are key enablers of critical applications along our customers' supply chain
Our products are key enablers of critical applications along our customers’ supply chain Self-Shopping Mark & Read Dimensioning & Weighing Systems Complete Traceability Mark & Trace 12
Slide 13: Retail
Retail Datalogic Proposition ▪ We meet the needs of retailers globally, from the distribution centers, through check-out, to the customer’s home ▪ Market Leader along the Retail supply chain from 1974 with the first scanner ever sold to a grocery store in Troy, Ohio up to now with the innovative fri
Slide 14: Manufacturing
Manufacturing Datalogic Proposition ▪ Leader in traceability thanks to the most complete and performing offer of stationary industrial scanners ▪ Unique portfolio provider of smart, interconnected devices able to protect, identify, sense, check and mark ▪ Datalogic is providing multi-product portfol
Slide 15: Transportation & Logistics
Transportation & Logistics Datalogic Proposition ▪ We ensure Data Collection to Courier-Express-Parcels, Airports and Logistics ▪ Datalogic is at the forefront of the development of airport systems, since 1984 with the first automatic reading station in Milan, to the recent contract with a main Euro
Slide 16: Healthcare
Healthcare Datalogic Proposition ▪ We empower the entire Healthcare ecosystem from drug production to patient care ▪ Datalogic is the sole company providing unique product features for the HC industry such as: Anti-microbial enclosures, Inductive charging technology for battery recharge, and Green s
Slide 17: New Product Launches and Innovation
New Product Launches and Innovation Mobile Computer Hand Held Scanners Sensors Memor K Gryphon 4500 DISINFECTANT Memor 10 Ethernet Introduction and ANTIMICROBIAL (DRA) Adaptor Models JOYA™ TOUCH A6 WITH Memor 20 ANDROID™ 8.1 Gryphon 4200 Series OREO S8 Series IO Link HANDSCANNER™ Skorpio X5 ❑ Vitali
Slide 18: Key Growth and Strategic Drivers
Key Growth and Strategic Drivers ▪ Keep focus on all of our verticals ▪ MFG ($7 bln): expand into new sectors Industry ▪ RTL ($ 3 bln): check out evolution, cross sell mobile, watch distribution centers carefully ▪ T&L ($2 bln): cross sell – complete offer SIS, Mobile, HHS ▪ Protect our leadership i
Slide 19: Financials & Outlook
Financials & Outlook 19
Slide 20: 9M 2020 Financial Highlights
9M 2020 Financial Highlights ❑ Effectively navigating through Covid-19 challenges ❑ Continue investing in Innovation during the providing operations continuity while protecting pandemic with R&D spending* at ca. 14.2% and our teams. Vitality Index at 21.8% ❑ Covid-19 pandemic impacting EMEAI and Ame
Slide 21: Group Revenues by Segment
Group Revenues by Segment 9M 2019 Var % % on DL Business Revenues €m 9M 2020 Restated* vs. 9M 2019 Retail 142.7 171.0 (16.6%) Channel Manufacturing 81.5 89.1 (8.5%) 18.3% Transportation & Logistics 38.5 58.3 (33.9%) Healthcare Healthcare 11.7 13.2 (11.3%) 3.5% Retail Channel 61.6 97.1 (36.6%) 42.5%
Slide 22: Group Revenues by Geography
Group Revenues by Geography 9M 2019 Var % % on Group Revenues €m 9M 2020 APAC Restated* vs. 9M 2019 15.9% EMEAI 179.6 233.0 (23.0%) Americas 112.3 155.5 (27.8%) EMEAI APAC 55.2 52.9 4.3% 51.7% Total Datalogic 347.1 441.4 (21.4%) Americas 32.4% ❑ EMEAI: Decline driven by softness in all end markets a
Slide 23: 9M 2020 P&L
9M 2020 P&L * ▪ Gross Margin at 46.1%, decrease driven by lower volumes and price/mix effects 9M 2019 Variance Constant €m 9M 2020 Restated Reported FX ▪ Operating expenses at €140.7m down 14.7% and - Revenues 24.7% in Q3 executing cost reduction plans to 347.1 441.4 (21.4%) (20.8%) Gross Margin 160
Slide 24: EBITDA Adj: actual vs last year
* EBITDA Adj: actual vs last year €m 71.1 23.2 37.2 (0.5) 0.9 (38.8) 4.8 (13.4) (10.2) EBITDA Adj. Volume Price Mix Productivity Structure INFX FX/other EBITDA Adj. 9M 2019 9M 2020 16.1% on Group 10.7% on Group Revenues Revenues Positive Items Negative Items * The comparative economic data as at 30
Slide 25: Net Debt & Cash Flow Analysis: Dec'19 – Sep'20
Net Debt & Cash Flow Analysis : Dec’19 – Sep’20 €m 37.2 (13.5) 13.4 (37.0) (0.5) (8.1) (6.8) (17.0) (7.5) (39.9) NFP EBITDA Ch TWC Capex* Taxes Financial Purchase Dividend Other NFP Dec 19 Charges Own Shares Payment Sep 20 Positive Items Negative Items * Including IFRS 16 impact, Sep’ 19 Restated Ca
Slide 26: 2020 Outlook
2020 Outlook ▪ In this unprecedent context, The Group has promptly reacted this fast-moving scenario implementing aggressive cost measures to protect business and profit ▪ Good signs of end markets recovery in all geographies in late Q3 and Q4 start. Despite the high degree of uncertainty about the
Slide 27: Contact
Contact IR CONTACTS NEXT EVENTS IR Manager Laura Bernardelli March 9, 2021 Tel. +39 051 3147109 FY 2020 Results IR Advisor March 23-25, 2021 Vincenza Colucci STAR Conference Milan CDR Communication Srl Tel. +39 335 6909547 April 29, 2021 vincenza.colucci@cdr-communication.it Shareholders’ Meeting IR
Slide 28: Forward-looking statements notice
This presentation contains statements that are neither reported financial results nor other historical information. These statements are forward-looking statements. These forward-looking statements rely on a number of assumptions and are subject to a number of risks and uncertainties, many of which